Renaissance Capital logo

US IPO Week Ahead: Market slowdown continues with no IPOs scheduled

March 4, 2022
Week Ahead

No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar during the week.

The typical February lull was quieter than expected, with few large filings and no launches after Presidents’ Day in light of the repercussions of war in Europe. There are a number of large issuers waiting in the pipeline once the IPO market becomes more amenable, led by Bausch Health spin-off Bausch + Lomb (BLCO) and Greek yogurt brand Chobani (CHO), which aims to be the latest public benefit corp to go public.

Street research is expected for four companies in the week ahead, and lock-up periods will be expiring for one company. For access to Street research and lock-up expiration dates, sign up for a free trial of IPO Pro.

IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 3/3/2022, the Renaissance IPO Index was down 26.5% year-to-date, while the S&P 500 was down 8.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Snowflake (SNOW). The Renaissance International IPO Index was down 21.8% year-to-date, while the ACWX was down 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Volvo Car Group and Kuaishou.